ScholarLens Back to search
2009•Unpublished venueRequires access

IN VITRO SUSCEPTIBILITY OF METHICILLIN-RESISTANT STAPHYLOCCOCCUS AUREUS TO LINEZOLID BY E-TEST METHOD

Nükhet Kurultay

Open publisher page 1 citations

Abstract

SUMMARY The incidence of methicillin-resistant gram-positive infections continue to increase and linezolid may provide new options to treat patients. The aim of this study was to investigate the in vitro susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens to linezolid. The in vitro susceptibility of a total of 88 MRSA isolates to linezolid was investigated by the E-test. All MRSA isolates were found to be susceptible to linezolid (Minimal inhibitory concentration < 4.0 mg/l). The results of the present study demonstrated that linezolid has a good in vitro activity against MRSA in Turkey. This drug could be a promising therapeutic option against MRSA.

About this research paper

What this paper is about

SUMMARY The incidence of methicillin-resistant gram-positive infections continue to increase and linezolid may provide new options to treat patients. The aim of this study was to investigate the in vitro susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens to linezolid. The in vitro susceptibility of a total of 88 MRSA isolates to linezolid was investigated by the E-test. All MRSA isolates were found to be susceptible to linezolid (Minimal inhibitory concentration < 4.0 mg/l). The results of the present study demonstrated that linezolid has a good in vitro activity against MRSA in Turkey. This drug could be a promising therapeutic option against MRSA.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

SUMMARY The incidence of methicillin-resistant gram-positive infections continue to increase and linezolid may provide new options to treat patients. The aim of this study was to investigate the in vitro susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens to linezolid. The in vitro susceptibility of a total of 88 MRSA isolates to linezolid was investigated by the E-test. All MRSA isolates were found to be susceptible to linezolid (Minimal inhibitory concentration < 4.0 mg/l). The results of the present study demonstrated that linezolid has a good in vitro activity against MRSA in Turkey. This drug could be a promising therapeutic option against MRSA.

Key concepts: Linezolid, Staphylococcus aureus, Microbiology, In vitro, Medicine, Methicillin-resistant Staphylococcus aureus, Minimum inhibitory concentration, Antibiotics

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
IN VITRO SUSCEPTIBILITY OF METHICILLIN-RESISTANT STAPHYLOCCOCCUS AUREUS TO LINEZOLID BY E-TEST METHOD — Research Paper | ScholarLens